AzTrials
AzTrials

Dentine HypersensitivityNCT02018783

Single Application of Desensitizing Pastes as Dentin Sensitivity Treatment

A study testing Colgate, Sensodyne and Nano P in people with Dentine Hypersensitivity, run by Federal University of São Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to evaluate the efficacy of three desensitizing toothpastes for immediate and intermediate-term relief of CDH, when compared with a control toothpaste. One hundred and thirty-eight hypersensitive teeth were diagnosed and randomized into four groups according to the therapeutic agent of each… Read more about this study

Who is it for?
Ages 22 to 48 yearsHealthy volunteers can take part
Conditions the study is for
Dentine Hypersensitivity
What is being tested?
Colgate, Sensodyne and Nano P
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
138 participants
Where
1 siteBrazil
Study dates
Apr 2013to Aug 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 48 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • subjects 18 years or older
  • in good general and oral health; have complaint of CDH in teeth distributed in all 4 quadrants
  • not making use of desensitizing agents
  • not having undergone periodontal treatment over the past 3 months
  • respond to evaporative stimulus with a score ≥ 1.5 cm on VAS

Who cannot join

  • patients who presented restorations and caries near the exposed dentin of the hypersensitive teeth
  • who made frequent use of painkillers, anti-inflammatory and antidepressants drugs

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Periodontics Clinic, Department of Dentistry

    Diamantina, Minas Gerais, 39100000

Other trials in Brazil

About this study

Official title: Clinical Evaluation of the Effectiveness of Immediate Relief Obtained With Desensitizing Creams - A Controlled, Randomized, Triple Masked, Split-Mouth Clinical Trial

The aim of this study was to evaluate the efficacy of three desensitizing toothpastes for immediate and intermediate-term relief of CDH, when compared with a control toothpaste. One hundred and thirty-eight hypersensitive teeth were diagnosed and randomized into four groups according to the therapeutic agent of each desensitizing cream tested: 1) strontium acetate and calcium carbonate, 2) calcium carbonate and arginine 8%, 3) calcium phosphate nanoparticles and 4) a control toothpaste. The desensitizing creams were applied according to the manufacturer's instructions. Cervical dentin hypersensitivity was assessed at baseline, immediately, 24 hours and 30 days after the treatment. Cold and evaporative tests were used to assess the sensitivity level.

Being tested
Colgate, Sensodyne, Nano P, Cocorico
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ColgateProcedure or surgery

    Slow-speed handpiece with a Robson brush for 3 seconds by repeating the procedure

  • SensodyneProcedure or surgery

    Digital application for 60 seconds.

  • Nano PProcedure or surgery

    Slow-speed handpiece with a Robson brush for 10 seconds

  • CocoricoProcedure or surgery

    Digital application for 60 seconds

Study groups in NCT02018783
Study groupRoleWhat they receive
SensodyneExperimentalDigital application for 60 seconds.
Receives: Procedure: Sensodyne
ColgateExperimentalSlow-speed handpiece with a Robson brush for 3 seconds by repeating the procedure
Receives: Procedure: Colgate
Nano PExperimentalSlow-speed handpiece with a Robson brush for 10 seconds
Receives: Procedure: Nano P
CocoricoPlacebo comparatorDigital application for 60 seconds
Receives: Procedure: Cocorico

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cervical dentin hypersensitivity

    The cervical dentin hypersensitivity was evaluated by an air blast (evaporative stimulus) for 5 seconds, and by a tetrafluoroethane spray (cold stimulus) for 5 seconds.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionAug 2013
  4. Study completionAug 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
138 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02018783
Sponsor's protocol ID
dessensibilizantes
Status last verified
Dec 2013
First submitted
7 Dec 2013
Last updated
23 Dec 2013
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Colgate, Sensodyne and Nano P in people with Dentine Hypersensitivity, run by Federal University of São Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cervical dentin hypersensitivity (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2013; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in